IRIS
SANTORO, Domenico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 21.631
NA - Nord America 16.220
AS - Asia 10.365
SA - Sud America 4.103
AF - Africa 310
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 16
Totale 52.666
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.829
RU - Federazione Russa 10.242
SG - Singapore 4.387
BR - Brasile 3.490
IT - Italia 3.210
CN - Cina 2.727
IE - Irlanda 2.299
SE - Svezia 1.929
HK - Hong Kong 1.086
DE - Germania 920
VN - Vietnam 718
FR - Francia 661
UA - Ucraina 505
FI - Finlandia 471
NL - Olanda 402
IN - India 395
GB - Regno Unito 352
AR - Argentina 230
PL - Polonia 202
CA - Canada 188
BD - Bangladesh 152
MX - Messico 129
TR - Turchia 120
IQ - Iraq 100
EC - Ecuador 97
ZA - Sudafrica 90
JP - Giappone 88
ID - Indonesia 81
CO - Colombia 71
AT - Austria 68
ES - Italia 65
UZ - Uzbekistan 65
PK - Pakistan 64
VE - Venezuela 63
BE - Belgio 58
MA - Marocco 52
CZ - Repubblica Ceca 44
CL - Cile 42
PY - Paraguay 40
AZ - Azerbaigian 31
KE - Kenya 30
PE - Perù 30
AE - Emirati Arabi Uniti 28
IL - Israele 28
PH - Filippine 28
RO - Romania 28
SA - Arabia Saudita 28
EG - Egitto 26
CI - Costa d'Avorio 25
JO - Giordania 25
NP - Nepal 25
TN - Tunisia 25
UY - Uruguay 25
AL - Albania 22
DZ - Algeria 22
CH - Svizzera 21
MY - Malesia 21
LT - Lituania 20
GR - Grecia 19
KZ - Kazakistan 19
DO - Repubblica Dominicana 18
KG - Kirghizistan 17
IR - Iran 15
BO - Bolivia 14
LB - Libano 14
AU - Australia 13
BG - Bulgaria 12
JM - Giamaica 12
GE - Georgia 11
OM - Oman 11
PS - Palestinian Territory 11
ET - Etiopia 10
EU - Europa 10
RS - Serbia 10
KR - Corea 9
LV - Lettonia 8
NO - Norvegia 8
AM - Armenia 7
BY - Bielorussia 7
CR - Costa Rica 7
CY - Cipro 7
NZ - Nuova Zelanda 7
PA - Panama 7
PT - Portogallo 7
SN - Senegal 7
SY - Repubblica araba siriana 7
BH - Bahrain 6
EE - Estonia 6
GT - Guatemala 6
HN - Honduras 6
MD - Moldavia 6
BA - Bosnia-Erzegovina 5
BN - Brunei Darussalam 5
HU - Ungheria 5
LK - Sri Lanka 5
NI - Nicaragua 5
TH - Thailandia 5
TJ - Tagikistan 5
XK - ???statistics.table.value.countryCode.XK??? 5
AO - Angola 4
Totale 52.598
Salva come PNG Salva come JPEG
Città #
Moscow 3.118
Ashburn 2.498
Dublin 2.293
Singapore 2.214
Dallas 2.098
Chandler 1.581
Jacksonville 1.099
Hong Kong 1.081
Beijing 979
Nyköping 959
The Dalles 566
Princeton 425
San Jose 420
Medford 392
Los Angeles 391
Lauterbourg 387
Messina 373
Cambridge 359
Dearborn 354
Des Moines 321
São Paulo 288
Oude Meer 280
New York 272
Boardman 252
Ann Arbor 242
Ho Chi Minh City 227
Munich 219
Buffalo 215
Rome 194
Warsaw 177
Milan 166
Hanoi 160
Hyderabad 148
Tianjin 130
San Mateo 120
Frankfurt am Main 114
Redondo Beach 114
Rio de Janeiro 105
Jinan 102
Woodbridge 102
Belo Horizonte 101
Guangzhou 100
Wilmington 94
Houston 90
Orem 87
Tokyo 81
Turku 75
Council Bluffs 74
Bremen 73
Santa Clara 70
Shenyang 66
Brasília 62
Catania 62
Montreal 61
Palermo 61
Seattle 61
Brooklyn 58
Tashkent 58
Denver 57
Nanjing 56
Nuremberg 56
Shanghai 56
Brussels 55
Curitiba 55
Chennai 52
Pune 52
Johannesburg 48
Stockholm 48
Ottawa 46
Porto Alegre 46
Helsinki 44
Campinas 41
Hebei 41
Mexico City 41
Baghdad 40
London 40
Vienna 40
Florence 39
Genova 38
Amsterdam 37
Turin 37
Poplar 36
Chicago 34
Guayaquil 34
Lancaster 34
Manchester 34
Bologna 33
Hangzhou 33
Zhengzhou 33
Boston 32
Düsseldorf 32
Jakarta 32
Ningbo 32
Norwalk 32
Shenzhen 32
Brno 31
Haikou 31
Salvador 31
Baku 30
Caxias do Sul 29
Totale 28.549
Salva come PNG Salva come JPEG
Nome #
La sindrome MIA ( malnutrizione-infiammazione-aterosclerosi nel paziente uremico 1.519
Amiloidosi renale e fibrosi cistica: Ruolo della terapia con colchicina 754
Terapia nutrizionale nell'IRC in fase conservativa: suggerimenti di pratica clinica e di applicazione delle linee guida 446
Henoch-Schonlein purpura associated with acetaminophen and codeine. 382
Impotence in the XVIII century as described by Gian Pietro Fusanacci and Tommaso Eduardo Beatty 283
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 243
[Periorbital purpura: a pathognomonic but late sign of AL amyloidosis] / Porpora periorbitaria: un segnale patognomonico ma tardivo di amiloidosi AL 238
[Lupus Nephritis and Enteritis, a dual simultaneous involvement with Arteriolar Thrombosis] 230
[Management of hyperphosphatemia in patients with chronic kidney disease] 228
[From hyponatremia to tolvaptan] 223
Metformin-related lactic acidosis: is it a myth or an underestimated reality? 222
A new approach to the evaluation of hyperphosphatemia in chronic kidney disease 221
[Complement factor B mutation in atypical hemolytic uremic syndrome. Rare cause of rare disease] 221
Association of higher advanced oxidation protein  products (AOPPs) levels in patients with diabetic  and hypertensive nephropathy 221
Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study 221
Association of VDR gene polymorphisms with heart disease in chronic kidney disease patients 207
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 207
Flavocoxid, a Natural Antioxidant, Protects Mouse Kidney from Cadmium-Induced Toxicity. 205
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 203
[Renal and extra-renal involvement in sclerodermia.] 197
Auxin induces cell proliferation in an experimental model of mammalian renal tubular epithelial cells 195
Sclerostin levels in uremic patients: a link between bone and vascular disease 194
Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease 191
Sevalamer Hydrochloride, Sevelamer Carbonate and Lanthanum Carbonate: In Vitro and In Vivo Effects on Gastric Environment 189
Defense mechanisms in hemodialysis-dependent patients 188
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 186
Association of parathyroid carcinoma and thyroid disorders: A clinical review 185
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study 185
Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure 183
Adaptation of the Mishel Uncertainty of Illness Scale (MUIS) for chronic patients in Italy 182
In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study 182
Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease 181
History of L-carnitine: Implications for renal disease 181
An update on calcium metabolism alterations and cardiovascular risk in patients with chronic kidney disease: questions, myths and facts. 181
ACCUMULO DI TECNEZIO IN METASTASI POLMONARI DA CARCINOMA DIFFERENZIATO TIROIDEO (CDT): UNA RARA EVENIENZA 178
Accidental discovery of lung metastases from differentiated thyroid cancer by 99mTc sodium pertechnetate scan in a patient with secondary hyperparathyroidism 178
Delayed graft function and chronic allograft nephropathy: Diagnostic and prognostic role of neutrophil gelatinase-associated lipocalin 177
ALTERAZIONI RENALI IN UN CASO DI CRIOGLOBULINEMIA MISTA DI TIPO 2 IN UN PAZIENTE AFFETTO DA LINFOMA CON CELLULE B. 176
Hypernatraemia and low eGFR at hospitalization in COVID-19 patients: a deadly combination 176
Beneficial effects of oral pure caffeine on oxidative stress 173
Endothelial dysfunction in chronic renal failure. 172
Kidney disease and psoriasis: novel evidences beyond old concepts 172
Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study 172
Circulating sclerostin and Dickkopf-1 correlate with vascular calcifications in non-dialysis chronic kidney disease 171
Chronic Kidney Disease Management in General Practice: A Focus on Inappropriate Drugs Prescriptions 171
Absorbable phosphate in medication 171
The concept of the urine test and specific reaction of the urine in various diseases according to Enrico Cauchi - member of the medical council of Malta (1933) 169
C3 glomerulopathy in cystic fibrosis: a casereport 167
A prospective, multicenter, randomized, controlled study: the Correction of Metabolic Acidosis with Use of Bicarbonate in Chronic Renal Insufficiency (UBI) Study 166
Impotence in the 18th and 19th century: concepts of etiology and approaches to therapy. 163
A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy 163
Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study 163
The Myth of Water and Salt: From Aquaretics to Tenapanor 163
Case report on pathogenetic link between gluten and IgA nephropathy 163
Stress ossidativo in una popolazione di ipertesi e nefropatici: utilità del dosaggio dell’AOPP 163
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents? 163
Thyroid hormone autoantibodies: Are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments? 162
A longitudinal study of sleep disorders in early-stage chronic kidney disease 161
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 160
Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis 159
[From scientific evidence to clinical recommendations: outlooks and challenges for the SIN (Italian Society of Nephrology)] 159
Negative Emotions in End-Stage Renal Disease: Are Anxiety Symptoms Related to Levels of Circulating Catecholamines? 158
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 157
Correction to: Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 157
Autonomic dysfunction in uremia 156
Analisi dei costi dell’eritropoietina in dialisi nella regione sicilia 156
Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression 156
The Management of Diabetes Mellitus in Patients with Chronic Kidney Disease: A Population-Based Study in Southern Italy 156
Vitamin D receptor polymorphism in chronic kidney disease patients with complicated cardiovascular disease 155
Autoimmune thyroiditis and glomerulopathies 154
Dense deposit disease in a child with febrile sore throat 153
Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis 153
Kidney biopsy in type 2 diabetic patients: Critical reflections on present indications and diagnostic alternatives 153
EFFECTIVENESS OF L-CARNITINE THERAPY IN UREMIC ANEMIA 152
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease 152
Nephro-oncology: a link in evolution 152
Dual αvβ3 and αvβ5 blockade attenuates fibrotic and vascular alterations in a murine model of systemic sclerosis 152
A Delphi consensus panel on nutritional therapy in chronic kidney disease 152
Choice of dialysis treatment and type of medical unit (private vs public): application of a recursive bivariate probit 150
Caso clinico di una bambina con lichen follicolare e sindrome nefrosica 150
Semaphorin 3A serum levels are influenced by haemodialysis: what clinical significance? 150
[Nutritional diet therapy in the management of the patient with Chronic Kidney Disease in advanced phase to delay the beginning and reduce the frequency of dialysis. An option also in the pre-emptive transplant program] 150
TERAPIA DELLE GLOMERULONEFRITI A LESIONI ISTOLOGICHE MINIME 149
Pain in Renal Disease. 148
Compliance ed emozioni in una popolazione di emodializzati 148
Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system 148
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 148
Socio-economic factors, food habits and phosphorus levels in patients on hemodialysis 148
Copy number variant analysis and genome-wide association study identify loci with large effect for vesicoureteral reflux 148
Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients 148
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review 148
Vascular access for hemodialysis: current perspectives 147
Cystic Fibrosis: A Risk Condition for Renal Disease 147
il Registro regionale siciliano di dialisi e trapianto 1997-1998:dati preliminari 146
Salt-water imbalance and fluid overload in hemodialysis patients: a pivotal role of corin 146
[Anti-SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases. Recommendations of the Italian Society on Nephrology's Working Group on Renal Immunopathology (Vaccine Task Force)] 146
Meccanismi di difesa in soggetti sottoposti a trattamento dialitico cronico 145
Squilibri idrico-salini e sovraccarico di liquidi nei pazienti dializzati, il ruolo centrale di Corin 145
Non-Invasive Imaging for Evaluating Cardiovascular Involvement in Patients with Primary and Lupus Nephritis. 145
ACUTE PARICALCITOL ADMINISTRATION REDUCE INFLAMMATION IN CKD PATIENTS IN VIVO AND IN VITRO 144
Totale 19.673
Salva come PNG Salva come JPEG
Categoria #
all - tutte 172.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 172.452
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021546 0 0 0 0 0 0 0 0 0 265 141 140
2021/20223.004 56 182 123 147 109 51 203 149 128 490 402 964
2022/20236.667 558 523 309 469 508 639 103 386 2.806 75 201 90
2023/20242.053 175 288 152 146 170 368 41 129 33 204 59 288
2024/20258.846 138 61 193 465 385 349 333 1.919 2.173 563 840 1.427
2025/202625.596 1.273 1.779 2.548 2.137 2.311 5.396 3.074 3.128 3.015 935 0 0
Totale 53.447